A new antibody treatment is being trialled amid hopes that it could prevent people from developing COVID-19 after being exposed to the disease.The antibody, known as AZD7442, has been developed by pharmaceutical company AstraZeneca and is being looked at by the University College London Hospitals NHS Trust as part of a new trial called Storm Chaser.
UCLH consultant virologist Dr Catherine Houlihan, who is leading the Storm Chaser trial, said: “We know that this antibody combination can neutralise the virus, so we hope to find that giving this treatment via injection can lead to immediate protection against the development …
